skolkov, conducted preclinical studies and the first phase is already on people of the alphabet.dministered to 21 russian patients with gastric cancer with multiple metastases, non-standard medicines. they didn’t help anymore, then some patients were severe, and in 68% of cases. we have achieved control over the disease, their tumor has ceased to develop these data, the oncologists presented at a congress in the united states, their report was chosen from the three most interesting for a special discussion. another patient. six lines of therapy received, and the body stuffed on after only 2 months of the appointment of the alphabet. the metastases themselves began to shrink. here, in particular, by 24%, one large by 7%. and most importantly, this patient is from may 2021, alive until he currently, the alphabet has shown itself to be not very tactful ahead, the second phase of the study is already 150%. alafanib has been shown to work in patients who have already exhausted standard therapy. that is, essentially. these patients are candidates for hospice. the first results have all